SGX94: Preliminary Phase II data

By WIR Staff | Jan 4, 2016 | 8:00 AM GMT

Preliminary data from a double-blind, placebo-controlled, U.S. Phase II trial in 111 patients undergoing chemoradiation for head and

Read the full 181 word article

How to gain access

Continue reading with a
two-week free trial.